Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (381-390 of 519) with videos related to

Pageof 52
Sort By:
Cancer Research|December 14, 2011
Common structural and epigenetic changes in the genome of castration-resistant prostate cancerTerence W Friedlander, Ritu Roy, Scott A Tomlins, et al.
The Prostate|November 2, 2018
Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Robert B Den, Maria I Carlo, et al.
Investigational New Drugs|August 22, 2012
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancerKenneth J Pienta, Jean-Pascal Machiels, Dirk Schrijvers, et al.
Cancer Research|December 18, 2004
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy programRajal B Shah, Rohit Mehra, Arul M Chinnaiyan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2019
Prospective Comparison of PET Imaging with PSMA-Targeted <sup>18</sup>F-DCFPyL Versus Na<sup>18</sup>F for Bone Lesion Detection in Patients with Metastatic Prostate CancerSteven P Rowe, Xin Li, Bruce J Trock, et al.
Advances in Radiation Oncology|April 14, 2020
Online Prostate-Specific Membrane Antigen and Positron Emission Tomography-Guided Radiation Therapy for Oligometastatic Prostate CancerWilliam T Hrinivich, Ryan Phillips, Angela J Da Silva, et al.
The Prostate|October 20, 2015
Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Joshua M Lang, Robert B Den, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 8, 2018
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on <sup>18</sup>F-DCFPyL PET/CT ImagingRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Nature Genetics|December 19, 2006
Integrative molecular concept modeling of prostate cancer progressionScott A Tomlins, Rohit Mehra, Daniel R Rhodes, et al.
Plos One|January 26, 2016
Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood SamplesPriya Gogoi, Saedeh Sepehri, Yi Zhou, et al.
Pageof 52

Showing results (381-390 of 519) with videos related to

Sort By:
Pageof 52
Cancer Research|December 14, 2011
Common structural and epigenetic changes in the genome of castration-resistant prostate cancerTerence W Friedlander, Ritu Roy, Scott A Tomlins, et al.
The Prostate|November 2, 2018
Tumor cell heterogeneity and resistance; report from the 2018 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Robert B Den, Maria I Carlo, et al.
Investigational New Drugs|August 22, 2012
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancerKenneth J Pienta, Jean-Pascal Machiels, Dirk Schrijvers, et al.
Cancer Research|December 18, 2004
Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy programRajal B Shah, Rohit Mehra, Arul M Chinnaiyan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2019
Prospective Comparison of PET Imaging with PSMA-Targeted <sup>18</sup>F-DCFPyL Versus Na<sup>18</sup>F for Bone Lesion Detection in Patients with Metastatic Prostate CancerSteven P Rowe, Xin Li, Bruce J Trock, et al.
Advances in Radiation Oncology|April 14, 2020
Online Prostate-Specific Membrane Antigen and Positron Emission Tomography-Guided Radiation Therapy for Oligometastatic Prostate CancerWilliam T Hrinivich, Ryan Phillips, Angela J Da Silva, et al.
The Prostate|October 20, 2015
Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Joshua M Lang, Robert B Den, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 8, 2018
Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on <sup>18</sup>F-DCFPyL PET/CT ImagingRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
Nature Genetics|December 19, 2006
Integrative molecular concept modeling of prostate cancer progressionScott A Tomlins, Rohit Mehra, Daniel R Rhodes, et al.
Plos One|January 26, 2016
Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood SamplesPriya Gogoi, Saedeh Sepehri, Yi Zhou, et al.
Pageof 52